Application no. and date | 16733268.3 (espacenet) (Federated) (European Patent Register), 20160616 | Patent/reg. no. and date | DK/EP 3310371, 20200930 | Publication date | 20180425 | Priority no. and date | US 201562182847 P, 20150622 | EP pub. no. and date |
EP 3310371 20180425 | Effective date | | Applicant/owner | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | Applicant ref. no. | V49871DK00 | Inventor | CHEN, Yanyun, c/o Eli Lilly and Company P.O. Box 6288
Indianapolis, Indiana 46206-6288, US, MEZO, Adam Robert, c/o Eli Lilly and Company P.O. Box 6288
Indianapolis, Indiana 46206-6288, US, QU, Hongchang, c/o Eli Lilly and Company P.O. Box 6288
Indianapolis, Indiana 46206-6288, US, VALENZUELA, Francisco Alcides, c/o Eli Lilly and Company P. O. Box 6288
Indianapolis, Indiana 46206-6288, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 38/00 (2006.01) , A61K 38/26 (2006.01) , A61P 1/00 (2006.01) , A61P 3/00 (2006.01) , C07K 14/00 (2006.01) , C07K 14/605 (2006.01) | Title | Glucagon og GLP-1-Co-agonistforbindelser | Int. application no. | US2016037818 | Int. publication no. | WO2016209707 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|